Table 1.
CVD | miRNA | Target genes | Biological role of miRNA | Ref. |
---|---|---|---|---|
Atherosclerosis | miR-10a | MAP3K7 and BTRC | Reduced expression of endothelial adhesion molecules and proinflammatory cytokines | 12 |
miR-126 | Dlk1 | Enhanced proliferation of endothelial cells | 15 | |
miR-155 | Hbp1 | Increased lipid uptake, synthesis of ROS, and foam cell formation | 17 | |
miR-33a | ABCA1 | Reduced cholesterol efflux and increased foam cell formation | 18 | |
miR-145 | KLF5 | Prevents neointima formation | 19 | |
miR-362 | ADAMTS1 | Prevents vascular smooth muscle cell proliferation and migration into the intima | 22 | |
Myocardial infarction (MI) | miR-1 | Kcnj2 and Gja1 | Decreased cardiac conductivity and induction of arrhythmias | 24 |
miR-433 | Azin1 | Activates TGF-β signaling to induce cardiac fibrosis | 25 | |
miR-24 | Gata2 and Pak4 | Induction of apoptosis of endothelial cells and reduced neovascularization of the ischemic myocardium | 26 | |
miR-134 | Kdm2a | Repression of myocardial angiogenesis after MI | 27 | |
Hypertension and hypertensive heart disease | miR-181a and miR-663 | REN | Downregulation may lead to higher renin expression in the renal cortex of hypertensive patients | 29 |
miR-143 | ACE2 | Downregulation may enhance ACE2 expression in the arteries of hypertensive patients | 30 | |
miR-26 | Gata4 | Prevents pressure overload-induced cardiac hypertrophy | 31 | |
miR-217 | Pten | Promotes cardiac hypertrophy via AKT pathway activation | 32 | |
miR-214 | Sirt3 | Enhances mitochondrial dysfunction and cardiac hypertrophy | 33 |
CVD: cardiovascular disease; ROS: reactive oxygen species; MI: myocardial infarction